163 related articles for article (PubMed ID: 2898182)
1. Factors influencing the pathogenicity of Entamoeba histolytica.
Soh CT
Yonsei Med J; 1988; 29(1):1-10. PubMed ID: 2898182
[No Abstract] [Full Text] [Related]
2. [Epidemiological role of Blattella germanica (L.) in amebiasis].
Ulewicz K; Wolańska M; Kruminis-Lozowska W
Wiad Parazytol; 1981; 27(1):43-7. PubMed ID: 6275613
[No Abstract] [Full Text] [Related]
3. Virulence of Entamoeba histolytica strains of human origin in Bombay to golden hamster.
Guirges SY
Jpn J Med Sci Biol; 1984 Jun; 37(3):125-30. PubMed ID: 6094892
[TBL] [Abstract][Full Text] [Related]
4. Entamoeba histolytica: pathogenic mechanisms, human immune response, and vaccine development.
Ravdin JI
Clin Res; 1990 Apr; 38(2):215-25. PubMed ID: 2186887
[No Abstract] [Full Text] [Related]
5. Entamoeba histolytica: a possible cause of pruritus.
Ganor S
Int J Dermatol; 1981 May; 20(4):261. PubMed ID: 6263812
[No Abstract] [Full Text] [Related]
6. Isoenzyme patterns of strains of Entamoeba histolytica isolated in British Columbia.
Proctor EM; Wong Q
Arch Invest Med (Mex); 1987; 18(2):151-6. PubMed ID: 2889434
[No Abstract] [Full Text] [Related]
7. Host-parasite relationships in amebiasis: conference report.
Petri WA; Clark CG; Diamond LS
J Infect Dis; 1994 Mar; 169(3):483-4. PubMed ID: 7908923
[TBL] [Abstract][Full Text] [Related]
8. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.
Ravdin JI; Guerrant RL
J Clin Invest; 1981 Nov; 68(5):1305-13. PubMed ID: 6271810
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis in amebiasis.
Tannich E
Infect Agents Dis; 1992 Feb; 1(1):22-3. PubMed ID: 1365524
[No Abstract] [Full Text] [Related]
10. Amebiasis: introduction, current status, and research questions.
Guerrant RL
Rev Infect Dis; 1986; 8(2):218-27. PubMed ID: 2871618
[TBL] [Abstract][Full Text] [Related]
11. [Amebiasis: implications of the recognition of Entamoeba dispar and the identification of Entamoeba moshkovskii in humans].
Chacín-Bonilla L
Invest Clin; 2010 Jun; 51(2):239-56. PubMed ID: 20928980
[TBL] [Abstract][Full Text] [Related]
12. Amebiasis now.
Ravdin JI
Am J Trop Med Hyg; 1989 Sep; 41(3 Suppl):40-8. PubMed ID: 2552852
[No Abstract] [Full Text] [Related]
13. Amebiasis: clinical and laboratory perspectives.
Reitano M; Masci JR; Bottone EJ
Crit Rev Clin Lab Sci; 1991; 28(5-6):357-85. PubMed ID: 1772585
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis in amebiasis.
Orozco E
Infect Agents Dis; 1992 Feb; 1(1):19-21. PubMed ID: 1365523
[No Abstract] [Full Text] [Related]
15. Entamoeba histolytica: a snapshot of current research and methods for genetic analysis.
Morf L; Singh U
Curr Opin Microbiol; 2012 Aug; 15(4):469-75. PubMed ID: 22664276
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis in amebiasis: is it genetic or acquired?
McKerrow JH
Infect Agents Dis; 1992 Feb; 1(1):11-4. PubMed ID: 1365521
[No Abstract] [Full Text] [Related]
17. Effect of lowering the peripheral level of 5-hydroxytryptamine in host on the virulence of Entamoeba histolytica.
Ahmad I; Sen PC; Kulkarni RB; Sen MR
Indian J Med Res; 1984 Jun; 79():741-3. PubMed ID: 6097538
[No Abstract] [Full Text] [Related]
18. Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.
Guo X; Houpt E; Petri WA
Curr Opin Immunol; 2007 Aug; 19(4):376-84. PubMed ID: 17702556
[TBL] [Abstract][Full Text] [Related]
19. Luminal host-defense mechanisms against invasive amebiasis.
Variyam EP
Trends Parasitol; 2007 Mar; 23(3):108-11. PubMed ID: 17258936
[TBL] [Abstract][Full Text] [Related]
20. Entamoeba histolytica: Five facts about modeling a complex human disease in rodents.
Mendoza Cavazos C; Knoll LJ
PLoS Pathog; 2020 Nov; 16(11):e1008950. PubMed ID: 33180884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
